Streetbeat News

Analyst Ratings

PCRX

In the last quarter, Pacira BioSciences (NASDAQ:PCRX) received 3 bullish and 1 somewhat bullish ratings from analysts. The average 12-month price target for the company is $67.75, a 7.19% decrease from the previous average of $73.00.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 12:00 pm

AFRM

Over the past 3 months, 15 analysts have published their opinion on Affirm Holdings (NASDAQ:AFRM) stock. The analysts have an average price target of $15.63, which is lower than the current price of $16.36. The current average has increased by 4.2% from the previous average price target of $15.00.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 12:00 pm

RUN

Analysts have provided various ratings for Sunrun (NASDAQ:RUN) within the last quarter, with 2 bullish, 1 somewhat bullish, and 5 indifferent. The average 12-month price target for Sunrun is $27.0, representing a 9.12% decrease from the previous average price target of $29.71.

Portfolio Pulse from Benzinga Insights

July 13, 2023 | 12:00 pm

DAL

DKNG

DPZ

GPOR

HOOD

MA

META

NFLX

PANW

PPC

UBER

Several companies have had their price targets adjusted by various analysts. Gulfport Energy, Uber, Robinhood, Pilgrim's Pride, Mastercard, Palo Alto Networks, Delta Air Lines, DraftKings, Netflix, Domino's Pizza, and Meta Platforms all saw changes in their price targets, with most maintaining their current ratings. The majority of these companies saw their shares rise in pre-market trading or at close on Wednesday.

Portfolio Pulse from Lisa Levin

July 13, 2023 | 11:59 am

CSL

Baird analyst Timothy Wojs maintains an Outperform rating on Carlisle Companies (NYSE:CSL) and raises the price target from $280 to $310.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 11:57 am

AVRO

Wells Fargo analyst Yanan Zhu has maintained an Overweight rating on Avrobio (NASDAQ:AVRO) but lowered the price target from $2.5 to $2.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 11:56 am

AHCO

Baird analyst Eric Coldwell maintains an Outperform rating on AdaptHealth (NASDAQ:AHCO) and raises the price target from $20 to $21.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 11:52 am

DPZ

Wells Fargo analyst Zachary Fadem has maintained an Equal-Weight rating on Domino's Pizza (NYSE:DPZ) and raised the price target from $310 to $375.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 11:50 am

DPZ

Baird analyst David Tarantino maintains a Neutral rating on Domino's Pizza (NYSE:DPZ) and raises the price target from $320 to $360.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 11:47 am

HUM

Wells Fargo analyst Stephen Baxter has maintained an 'Overweight' rating on Humana (NYSE:HUM) but lowered the price target from $610 to $541.

Portfolio Pulse from Benzinga Newsdesk

July 13, 2023 | 11:46 am